Nanoparticulate Combination of Drugs for the Treatment of Osteosarcoma: A Review

Abstract

Malignancy speaks to a gathering of heterogeneous ailments described by uncontrolled development and spread of abnormal cells, at last leading to death. Nanomedicine assumes a huge job in the advancement of nanodrugs, nanodevices, drug delivery systems as well as nanocarriers. A portion of the significant issues in the treatment of cancer are multidrug resistance (MDR), restricted helpful window and undesired symptoms of accessible anticancer drug and the constraints of anticancer drugs. A few nano systems being used for recognition, determination and treatment, for example, theranostic bearers, liposomes, carbon nanotubes, quantum spots, polymeric micelles, dendrimers and metallic nanoparticles. Nonetheless, non-biodegradable nanoparticles cause high tissue aggregation and prompts harmfulness. MDR is viewed as a significant obstruction to disease treatment because of metastatic tumors that create protection from chemotherapy. MDR adds to the disappointment of chemotherapies in different diseases, including bosom, ovarian, lung, gastrointestinal and hematological malignancies. In addition, the helpful proficiency of anticancer medications or nanoparticles (NPs) utilized alone is not as much as that of the blend of NPs and anticancer drugs. Blend treatment has for quite some time been received first choice of the treatment of a few malignancies to improve the clinical result. Combination treatment with anticancer medications has been appeared to for the most part instigate synergistic medication activities and discourage the beginning of medication opposition. We initially give a far reaching outline of the angiogenesis and of the various kinds of NPs at present utilized in medicines of malignant growth; those accentuated in this survey are liposomal system, polymeric nanoparticles, polymeric micelles PMs, dendrimers, carbon nanoparticles, nanodiamond ND, fullerenes, carbon nanotubes CNTs, graphene oxide GO, GO nanostructured and metallic nanoparticles utilized for combination treatment with different anticancer agent. Nanotechnology has given the advantageous tools to combination treatment. However, for clinical interpretation, we need proceeded with enhancements in the field of nanotechnology.

Authors and Affiliations

Sujit Desai*2, Dr. Preeti Khulbe1, Dr. Arehalli Manjappa

Keywords

Related Articles

Plant profile, phytochemistry and pharmacological properties of Ceratophyllum demersum Linn.: A review

Ceratophyllum demersum Linn.(CD) from the family Ceratophyllaceae is the significant & appealing marine macrophyte that has a slight affirmation in customary arrangement of medication as an pain relieving, antipyretics,...

Phytochemical Investigation & Antibacterial Activity of Hydroethanolic Leaf Extract of Grewia Hirsuta Collected From Forest

Traditional medicine (herbs) is an important part of life in developing world. The plant contains various secondary metabolites, some of exhibits proved antimicrobial properties that can beneficial in antimicrobial treat...

PSORIASIS: A COMPREHENSIVE REVIEW

From the reported epidemiological studies it has been observed that the psoriasis is more prevalent in adult mostly from North India i.e. 0.44 to 2.8% whereas the prevalence of the disease in the children is found very l...

Recent Development of COVID 19 Vaccines In Pandemic Condition

Covid-19, a disease caused by SARS-COV2 found highly contagious. In December 2019 first patient with symptoms like pneumonia of unknown cause was found in wuhan, china. During investigation Chinese health care found vira...

Nanoparticulate Combination of Drugs for the Treatment of Osteosarcoma: A Review

Malignancy speaks to a gathering of heterogeneous ailments described by uncontrolled development and spread of abnormal cells, at last leading to death. Nanomedicine assumes a huge job in the advancement of nanodrugs, na...

Download PDF file
  • EP ID EP689669
  • DOI -
  • Views 187
  • Downloads 0

How To Cite

Sujit Desai*2, Dr. Preeti Khulbe1, Dr. Arehalli Manjappa (2020). Nanoparticulate Combination of Drugs for the Treatment of Osteosarcoma: A Review. Suresh Gyan Vihar University Journal of Pharmaceutical Research and Education, 5(1), -. https://europub.co.uk/articles/-A-689669